🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Meningeal Neoplasms

Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles) NCT04427384n/a54 sites📍 Phoenix📍 Little Rock📍 Castro Valley GT Medical Technologies, Inc. · Tests: GammaTile Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures NCT07493447EARLY Phase 11 site📍 Nashville Eben Rosenthal · Tests: Panitumumab-IRDye800 NK Cell Therapy for Malignant Solid Brain Tumors NCT07552233NA4 sites📍 Beijing📍 Qinhuangdao📍 Zhengzhou Peking University Third Hospital · Tests: Autologous NK cells Multicenter Trial on Surgical Outcome and Quality of Life in Juxta-medullary Tumors NCT07056023n/a1 site📍 Münster University Hospital Muenster Neurocognitive Impact of Different Irradiation Modalities for Patients With Grade I-II Skull Base Meningioma: NCT06036706NA3 sites📍 Caen📍 Le Havre📍 Rouen Centre Francois Baclesse · Tests: Normo-fractionated intensity-modulated brain irradiation with or without stereotactic positioning, Hypo-fractionated st… Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide NCT04997317Phase 1, Phase 21 site📍 Basel University Hospital, Basel, Switzerland · Tests: 177Lu-DOTA-JR11 (Phase 0); Cycle 1 and Cycle 2 (cross-over), 177Lu-DOTATOC (Phase 0); Cycle 1 and Cycle 2 (cross-over),… Feasibility of Acquiring Hyperpolarized Imaging in Patients With Meningioma NCT06014905Phase 11 site📍 San Francisco Charlie Wang, MD, PhD · Tests: Hyperpolarized carbon C 13 pyruvate, Magnetic Resonance Image (MRI), Saline 177Lu-DOTATATE for Recurrent Meningioma NCT06326190Phase 219 sites📍 Innsbruck📍 Vienna📍 Lyon European Organisation for Research and Treatment of Cancer … · Tests: Local standard of Care, 177Lu-DOTATATE Proton Therapy Research Infrastructure- ProTRAIT- Neuro-oncology NCT04648462n/a3 sites📍 Maastricht📍 Groningen📍 Delft Maastricht Radiation Oncology · Tests: ProTRAIT Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site📍 Boadilla del Monte Fundación de investigación HM · Tests: Olaparib; 177Lu-DOTATATE Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer NCT01137643n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center · Tests: biologic sample preservation procedure, cytology specimen collection procedure Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial NCT06132685Phase 21 site📍 Atlanta Emory University · Tests: Biospecimen Collection, Computed Tomography, Dexamethasone, Magnetic Resonance Imaging, Questionnaire Administration Non Interventional German Leptomeningeal Disease Register NCT06146010n/a7 sites📍 Bonn📍 Mannheim📍 München University Hospital Tuebingen · Tests: No intervention Exploration of the Application of Methotrexate-loaded Drug Vesicles in Intrathecal Injection for Meningeal Metastasis of Lung Cancer NCT07559097Phase 1, Phase 21 site📍 Zhengzhou Henan Cancer Hospital · Tests: Methotrexate-loaded vesicles Furmonertinib Combined With Intrathecal Chemotherapy and Stereotactic Radiotherapy (SRT) for EGFR-Mutated NSCLC Patients With Brain Parenchymal and Leptomeningeal Metastases NCT07304739Phase 23 sites📍 Cangzhou📍 Tianjin📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: Furmonertinib, Intrathecal chemotherapy, Stereotactic radiotherapy Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis NCT06643000NA2 sites📍 Zhengzhou📍 Zhengzhou Henan Cancer Hospital · Tests: furmonertinib Multiple Dose Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases NCT07098806Phase 1, Phase 21 site📍 San Antonio Cerenome · Tests: 186RNL Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC NCT05805631Phase 21 site📍 Taipei Taipei Veterans General Hospital, Taiwan · Tests: Pemetrexed Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC NCT06663306Phase 11 site📍 Shanghai Shanghai Chest Hospital · Tests: Pemetrexed, Bevacizumab Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial NCT06500481Phase 358 sites📍 Phoenix📍 Little Rock📍 Encinitas NRG Oncology · Tests: Biospecimen Collection, Computed Tomography, Involved-Field Radiation Therapy, Lumbar Puncture, Magnetic Resonance Imag… Dual-targeting VEGFR1 and PD-L1 CAR-T for Pleural, Peritoneal, or Leptomeningeal Metastases NCT05477927Phase 11 site📍 Chengdu Sichuan University · Tests: Dual-targeting VEGFR1/PD-L1 CAR-T cells Embolization for Meningioma NCT05416567NA1 site📍 Trondheim St. Olavs Hospital · Tests: Endovascular embolization Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology NCT04988009n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Electronic Health Record Review, Survey Administration Neoadjuvant Stereotactic Radiotherapy for Brain Metastasis NCT06933199NA4 sites📍 Ostrava📍 Brno📍 Hradec Králové University Hospital Ostrava · Tests: Neoadjuvant Stereotactic Radiotherapy (NaSRT), Postoperative Stereotactic Radiotherapy (SRT) Cabozantinib for Patients With Recurrent or Progressive Meningioma NCT05425004Phase 23 sites📍 Miami📍 New York📍 Nashville Baptist Health South Florida · Tests: Cabozantinib Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study NCT07398599NA1 site📍 Nanchang Second Affiliated Hospital of Nanchang University · Tests: a combined regimen consisting of double-dose third-generation EGFR-TKI, bevacizumab, and intrathecal chemotherapy in pa… Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26) NCT05112549Phase 19 sites📍 Bonn📍 Freiburg im Breisgau📍 Heidelberg University Hospital Tuebingen · Tests: Nivolumab [Opdivo] The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction NCT06874426n/a3 sites📍 Leuven📍 Frankfurt am Main📍 Leiden Universitaire Ziekenhuizen KU Leuven · Tests: Endoscopic endonasal skull base surgery Translation and Validation of the MQOL Self-questionnaire Into French for Assessing Quality of Life in Patients With Meningiomas NCT07044076n/a1 site📍 Paris Centre Hospitalier St Anne · Tests: Quality of life Apatinib in the Treatment of Recurrent Atypical/malignant Meningioma in Adults NCT04501705NA1 site📍 Beijing Beijing Sanbo Brain Hospital · Tests: Apatinib Mesylate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy